ETEmma Tomalty

Emma Tomalty

*This is an algorithmically generated author record based on publicly available information.

Emma Tomalty has a total of 44 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Variability of Clinical Metrics in Small Population Communities Drive Perceived Wastewater and Environmental Surveillance Data Quality: Ontario, Canada-Wide Study

    by Nada Hegazy, K. Ken Peng, Patrick M. D’aOust, Lakshmi Pisharody, Elisabeth Mercier, Nathan Thomas Ramsay, Pervez Kabir, Tram Bich Nguyen, Emma Tomalty, Felix Addo, et al.

    The emergence of COVID-19 in Canada has led to over 4.9 million cases and 59,000 deaths by May 2024. Traditional clinical surveillance metrics (hospital admissions and clinical laboratory-positive cases) were complemented with wastewater and environmental monitoring (WEM) to monitor SARS-CoV-2 incidence. However, challenges in public health integration of WEM persist due to perceived limitations of WEM data quality, potentially driving inconsistent correlations variability and lead times. This study investigates how factors like population size, WEM measurement magnitude, site isolation status, hospital admissions, and clinical laboratory-positive cases affect WEM data correlations and variability in Ontario. The analysis uncovers a direct relationship between clinical surveillance data and the population size of the surveyed sewersheds, while WEM measurement magnitude was not directly impacted by population size. Higher variability in clinical surveillance data was observed in smaller sewersheds, likely reducing correlation strength for inferring COVID-19 incidence. Population size significantly influenced correlation quality, with thresholds identified at ∼66,000 inhabitants for strong WEM-hospital admissions correlations and ∼68,000 inhabitants for WEM-laboratory-positive cases during waned vaccination periods in Ontario (the Omicron BA.1 wave). During significant vaccination immunization (the Omicron BA.2 wave), these thresholds increased to ∼187,000 and 238,000, respectively. These findings highlight the benefit of WEM for strategic public health monitoring and interventions, especially in smaller communities. This study provides insights for enhancing public health decision making and disease monitoring through WEM, applicable to COVID-19 and potentially other diseases.


  • Open Access

    Detection of Measles Virus Genotype A in a Non-Endemic Wastewater Setting: Insights from Measles Wastewater and Environmental Monitoring in Canada’s Capital Region

    by Emma Tomalty, Élisabeth Mercier, Lakshmi Pisharody, Tram Nguyen, Xin Tian, Pervez Kabir, Chandler Wong, Felix Addo, Nada Hegazy, Elizabeth Renouf, et al.

    The recent global resurgence of measles in 2023-2024, despite vaccine preventability, underscores a critical public health issue, largely due to reduced vaccination coverage during the SARS-CoV-2 pandemic. In response, Ottawa Public Health intensified vaccination efforts in 2023 and 2024. Additionally, a research initiative began in April 2024 to monitor Ottawa wastewater for measles virus (MeV) using established wastewater and environmental surveillance (WES) protocols. Unexpected positive MeV detections through RT-qPCR in Ottawa wastewater-despite no active regional cases-prompted genotypic and retrospective analyses of archived RNA samples dating back to 2020. The genotypic analysis identified positive detection to belong to genotype A, the progenitor strain of the viral vaccines, marking the first report of MeV vaccine RNA in a large catchment area. Linear regression analysis revealed detections aligned with intensified vaccination efforts by Ottawa Public Health. These findings emphasize the importance of integrating genotypic analysis into WES practices to mitigate possible confounding factors, such as vaccine shedding into wastewater. Additionally, this research highlights potential public health applications using MeV WES as a complementary tool. Implementing the findings of this study for MeV WES, and for other re-emerging viruses, could improve public health response and resource allocation.